Sun Pharma scrip gains 4% on launch of generic Gleevec in US next year

Sun Pharma has received approval from the US Food and Drug Administration (USFDA) to launch generic version of its anti-cancer drug Gleevec (Imatinib Mesylate) tablets, 100 mg and 400 mg.